Anti-D immunoglobulin in pregnancy: what to know

Blood can pass between the pregnant person and fetus during pregnancy, birth, bleeding, abdominal injury, or certain procedures. If the pregnant person is RhD negative and the fetus is RhD positive, the immune system may recognise the RhD marker as unfamiliar and produce antibodies. This is called sensitisation. Anti-D contains ready-made antibodies that help clear RhD-positive cells before the immune system makes a lasting response. It is preventive care; it does not change the baby's blood type and does not treat every cause of bleeding.

Your maternity team uses blood-group testing and the circumstances of the pregnancy to decide whether anti-D is appropriate. The timing can vary after an event that might allow blood mixing, and it may also be offered at a planned stage of pregnancy or after birth when indicated.

Tell your maternity team promptly about vaginal bleeding, a fall or blow to your abdomen, pregnancy loss, an ectopic pregnancy concern, or a procedure involving the uterus. Give them the time of the event and mention any previous anti-D treatment or known blood-group result. Keep the appointment or ask how quickly you should attend, because the useful timing depends on why the injection is being considered. Do not delay urgent assessment while trying to arrange the injection yourself.

After treatment, keep the record with your pregnancy notes and tell future clinicians that you received anti-D. It can affect how antibody results are interpreted for a period of time.

Contact your maternity unit urgently for heavy bleeding, severe or one-sided abdominal pain, fainting, shoulder pain, fever, or reduced fetal movement later in pregnancy. These symptoms need assessment for their own reasons; anti-D does not replace an examination. Seek emergency help if you feel seriously unwell or have trouble breathing.

Ask whether your blood group and antibody screen indicate a need for anti-D, which event has prompted the recommendation, when it should be given, and what follow-up testing is planned. You can also ask what symptoms should lead you to return and how the treatment will be recorded.